During the past decade, University of Michigan Comprehensive Cancer Center conducted 363 clinical trials. In the 10-year time frame, 363 clinical trials started and 265 clinical trials were completed, i.e. on average, 73% percent of trials that started reached the finish line to date. In the past 5 years, 133 clinical trials started and 126 clinical trials were completed. i.e. 94.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Michigan Comprehensive Cancer Center" #1 sponsor was "University of Michigan Rogel Cancer Center" with 171 trials, followed by "SWOG Cancer Research Network" with 150 trials sponsored, "National Cancer Institute (NCI)" with 148 trials sponsored, "Radiation Therapy Oncology Group" with 62 trials sponsored and "Alliance for Clinical Trials in Oncology" with 62 trials sponsored. Other sponsors include 354 different institutions and companies that sponsored additional 148 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 410 trials as a collaborator, "NRG Oncology" with 40 trials as a collaborator, "SWOG Cancer Research Network" with 26 trials as a collaborator, "Cancer and Leukemia Group B" with 25 trials as a collaborator and "Eastern Cooperative Oncology Group" with 20 trials as a collaborator. Other collaborators include 276 different institutions and companies that were collaborators in the rest 157 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan Comprehensive Cancer Center" are "Breast Cancer" (65 trials), "Prostate Cancer" (58 trials), "Leukemia" (39 trials), "Lung Cancer" (37 trials) and "Lymphoma" (32 trials). Many other conditions were trialed in "University of Michigan Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Michigan Comprehensive Cancer Center" are "Drug" (746 trials), "Other" (221 trials), "Radiation" (184 trials), "Biological" (170 trials) and "Procedure" (167 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (110 trials), "radiation therapy" (72 trials), "Quality-of-Life Assessment" (54 trials), "cisplatin" (41 trials) and "cyclophosphamide" (41 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan Comprehensive Cancer Center" are 740 trials for "All" genders, 114 trials for "Female" genders and 68 trials for "Male" genders.

Currently, there are 305 active trials in "University of Michigan Comprehensive Cancer Center". 3 are not yet recruiting, 123 are recruiting, 178 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 489 completed trials in University of Michigan Comprehensive Cancer Center, undefined suspended trials, and 97 terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan Comprehensive Cancer Center, 168 "Phase 1" clinical trials were conducted, 484 "Phase 2" clinical trials and 258 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 54 trials that are defined as “Not Applicable".

University of Michigan Comprehensive Cancer Center has several departments that took part in Clinical trials: "Ann Arbor Clinical Research" - 3 trials